Search results
Contineum, a startup born from a Roche buyout, files for IPO
BioPharma Dive via Yahoo Finance· 3 months agoDive Brief: Biotechnology startup Contineum Therapeutics has outlined plans for an initial public...
12 Most Advanced Countries in Biotechnology
Insider Monkey via Yahoo Finance· 2 years agoIn this article, we take a look at the 12 most advanced countries in biotechnology. You can skip our detailed analysis of the sector and go directly to 5...
A new startup from Feng Zhang and an ex-Illumina executive zeroes in on the epigenome
BioPharma Dive via Yahoo Finance· 6 months agoTo build a new biotechnology startup, Alex Aravanis looked to the past. The former Illumina and...
Novo taps Flagship startups to develop drugs for obesity, MASH
BioPharma Dive via Yahoo Finance· 6 months agoDive Brief: After finding incredible success with Ozempic and Wegovy, Novo Nordisk is enlisting the...
Maze lands new partner for Pompe drug, after Sanofi pact came apart
BioPharma Dive via Yahoo Finance· 1 month agoDive Brief: Biotechnology startup Maze Therapeutics has licensed a Pompe disease drug to Shionogi,...
AltruBio lands up to $225M after shift to immune drug research
BioPharma Dive via Yahoo Finance· 1 month agoDive Brief: Biotechnology startup AltruBio on Tuesday raised a Series B round that could hand it up...
J&J, Novo support Asgard’s push to make ‘in vivo’ cell therapies
BioPharma Dive via Yahoo Finance· 3 months agoAsgard Therapeutics has become the latest emerging developer of “in vivo” cell therapies to attract...
Frontier gets $80M, Galapagos’ backing to make a better KRAS drug
BioPharma Dive via Yahoo Finance· 4 months agoBiotechnology startup Frontier Medicines has pulled in $80 million in new funding to support a...
Alumis readies IPO to fund rival drug to Bristol Myers’ Sotyktu
BioPharma Dive via Yahoo Finance· 2 weeks agoDive Brief: Biotechnology startup Alumis on Friday outlined plans for an initial public offering...
Gene editing startup Metagenomi files for an IPO
BioPharma Dive via Yahoo Finance· 5 months agoDive Brief: Metagenomi, a biotechnology startup working to identify new CRISPR enzymes for editing genes, has filed to go public. Backed by healthcare...
